MELANIE MARTIN: Open Payments
NPI 1518503945 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,511 in 9 payments from 9 companies in 2025. Trend: 2023 $614 · 2024 $3,049 · 2025 $1,511
Food & beverage: $836Consulting: $675
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 1 | $675 |
| Chiesi USA, Inc. | 1 | $133 |
| ARGENX US, INC. | 1 | $125 |
| Janssen Pharmaceuticals, Inc | 1 | $119 |
| Aimmune Therapeutics, Inc. | 1 | $110 |
| Baxter Healthcare | 1 | $100 |
| Medtronic, Inc. | 1 | $93 |
| Teva Pharmaceuticals USA, Inc. | 1 | $84 |
| TG Therapeutics, Inc. | 1 | $72 |
Products named: VIVITROL, CLEVIPREX, VYVGART, INVEGA SUSTENNA, ZENPEP, Hillrom - Carnation Ambulatory Monitor, SYMPLICITY G3, AUSTEDO XR.
Industry payments across AZ — which companies pay providers there.
